MannKind (MNKD) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

MannKind Revenue Highlights


Latest Revenue (Y)

$198.96M

Latest Revenue (Q)

$19.73M

Main Segment (Y)

License and Service

MannKind Revenue by Period


MannKind Revenue by Year

DateRevenueChange
2023-12-31$198.96M99.42%
2022-12-31$99.77M32.25%
2021-12-31$75.44M15.81%
2020-12-31$65.14M3.34%
2019-12-31$63.04M126.28%
2018-12-31$27.86M137.20%
2017-12-31$11.74M-93.28%
2016-12-31$174.76M100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--100.00%
2012-12-31$35.00K-30.00%
2011-12-31$50.00K-46.24%
2010-12-31$93.00K100.00%
2009-12-31--100.00%
2008-12-31$20.00K100.00%
2007-12-31$10.00K-90.00%
2006-12-31$100.00K100.00%
2005-12-31-100.00%
2004-12-31-100.00%
2003-12-31-100.00%
2002-12-31--100.00%
2001-12-31$326.00K111.69%
2000-12-31$154.00K-

MannKind generated $198.96M in revenue during NA 2023, up 99.42% compared to the previous quarter, and up 714.17% compared to the same period a year ago.

MannKind Revenue by Quarter

DateRevenueChange
2024-09-30$19.73M-72.75%
2024-06-30$72.39M9.24%
2024-03-31$66.26M13.32%
2023-12-31$58.47M14.09%
2023-09-30$51.25M5.43%
2023-06-30$48.61M19.65%
2023-03-31$40.63M12.67%
2022-12-31$36.06M9.85%
2022-09-30$32.83M73.73%
2022-06-30$18.89M57.56%
2022-03-31$11.99M-4.18%
2021-12-31$12.52M-43.65%
2021-09-30$22.21M-4.59%
2021-06-30$23.28M33.52%
2021-03-31$17.44M-5.46%
2020-12-31$18.44M20.13%
2020-09-30$15.35M1.57%
2020-06-30$15.11M-6.90%
2020-03-31$16.23M1.51%
2019-12-31$15.99M9.58%
2019-09-30$14.60M-2.71%
2019-06-30$15.00M-14.02%
2019-03-31$17.45M8.83%
2018-12-31$16.03M258.74%
2018-09-30$4.47M14.80%
2018-06-30$3.89M12.35%
2018-03-31$3.46M-23.51%
2017-12-31$4.53M121.73%
2017-09-30$2.04M-5.55%
2017-06-30$2.16M-28.12%
2017-03-31$3.01M-75.74%
2016-12-31$12.40M-92.36%
2016-09-30$162.35M100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31--100.00%
2012-09-30$35.00K100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30--100.00%
2011-03-31$50.00K100.00%
2010-12-31-100.00%
2010-09-30--100.00%
2010-06-30$93.00K100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30--100.00%
2008-03-31$20.00K100.00%
2007-12-31--

MannKind generated $19.73M in revenue during Q3 2024, up -72.75% compared to the previous quarter, and up 40.58% compared to the same period a year ago.

MannKind Revenue Breakdown


MannKind Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
License and Service$41.91M----
Product-$56.25M$39.17M$32.32M-
Royalty-$15.60M---
Service-$3.10M---
Product Sales-$81.07M---
License And Service--$22.02M$9.56M$7.90M

MannKind's latest annual revenue breakdown by segment (product or service), as of Dec 23: License and Service (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Product$19.73M$17.44M$16.26M$12.72M$9.83M$11.34M$9.75M$10.06M$7.28M-----------
License And Service$23.27M$14.78M$10.68M$8.71M$7.14M$6.08M$5.51M$3.29M$2.63M$1.58M$1.98M$3.36M$2.39M$1.84M------
Royalty$27.08M$9.07M$6.22M$304.00K----------------
License and Service--$22.64M$10.26M$9.01M---------------
Service------$513.00K$430.00K$1.17M-----------
Product Sales------$26.47M$26.18M$17.42M-----------

MannKind's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Royalty (38.65%), License And Service (33.20%), and Product (28.15%).

MannKind Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BMRNBioMarin Pharmaceutical$2.42B$733.87B
UTHRUnited Therapeutics$2.33B$748.90M
TECHBio-Techne$1.16B$289.46M
LEGNLegend Biotech$285.14M$93.99M
KNSAKiniksa Pharmaceuticals$270.26M$112.21M
MNKDMannKind$198.96M$19.73M
SGMOSangamo Therapeutics$176.23M$356.00K
ADAPAdaptimmune Therapeutics$60.28M$128.23M
LQDALiquidia$17.49M$4.45M
AFMDAffimed$8.28M$155.00K
IMMPImmutep$3.51M$2.11M
SABSSAB Biotherapeutics$2.24M$263.14K
VSTMVerastem-$10.00M
INKTMiNK Therapeutics--
PCVXVaxcyte--
DAWNDay One Biopharmaceuticals-$20.07M
ELEVElevation Oncology--
LRMRLarimar Therapeutics--
ACERAcer Therapeutics-$371.79K
KTTAPasithea Therapeutics--

MNKD Revenue FAQ


What is MannKind’s yearly revenue?

MannKind's yearly revenue for 2023 was $198.96M, representing an increase of 99.42% compared to 2022. The company's yearly revenue for 2022 was $99.77M, representing an increase of 32.25% compared to 2021. MNKD's yearly revenue for 2021 was $75.44M, representing an increase of 15.81% compared to 2020.

What is MannKind’s quarterly revenue?

MannKind's quarterly revenue for Q3 2024 was $19.73M, a -72.75% decrease from the previous quarter (Q2 2024), and a -61.51% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $72.39M, a 9.24% increase from the previous quarter (Q1 2024), and a 48.91% increase year-over-year (Q2 2023). MNKD's quarterly revenue for Q1 2024 was $66.26M, a 13.32% increase from the previous quarter (Q4 2023), and a 63.10% increase year-over-year (Q1 2023).

What is MannKind’s revenue growth rate?

MannKind's revenue growth rate for the last 3 years (2021-2023) was 163.73%, and for the last 5 years (2019-2023) was 215.62%.

What are MannKind’s revenue streams?

MannKind's revenue streams in c 23 are License and Service

What is MannKind’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of MannKind was License and Service. This segment made a revenue of $41.91M, representing 100.00% of the company's total revenue.